labuxtinib   Click here for help

GtoPdb Ligand ID: 12870

Synonyms: Compound 1 [WO2022109595] | example F91 [WO2013033070] | THB-335 | THB335
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: The structure for labuxtinib was obtained from proposed INN list 129 (August 2023) where it is described as a tyrosine kinase inhibitor and antineoplastic agent. Patent information suggests that it is a KIT inhibitor [1-2]. It is most likely that labuxtinib is the INN for Third Harmonic Bio's candidate KIT inhibitor THB335. Development of the initial clinical lead THB001 was discontinued in late 2022 when hepatotoxicity was observed in a phase 1b study. THB335 is a follow-up molecule with structural modifications to address the toxicity risk, and is still in active development. As of January 2025 no structures have been formally declared for either of these inhibitors.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 78.65
Molecular weight 377.37
XLogP 1.6
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=CC=C(C=C1NC(=O)C2=CN=C3C=CC=CN23)C4=NOC(=N4)[C@H]5C[C@@H]5F
Isomeric SMILES F[C@@H]1[C@H](C1)C2=NC(=NO2)C=3C=CC(=C(C3)NC(=O)C4=CN=C5N4C=CC=C5)C
InChI InChI=1S/C20H16FN5O2/c1-11-5-6-12(18-24-20(28-25-18)13-9-14(13)21)8-15(11)23-19(27)16-10-22-17-4-2-3-7-26(16)17/h2-8,10,13-14H,9H2,1H3,(H,23,27)/t13-,14-/m0/s1
InChI Key RHNJOZCVGSBEAG-KBPBESRZSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Classification Click here for help
Compound class Synthetic organic
IUPAC Name Click here for help
N-[5-[5-[(1R,2S)-2-fluorocyclopropyl]-1,2,4-oxadiazol-3-yl]-2-methylphenyl]imidazo[1,2-a]pyridine-3-carboxamide
International Nonproprietary Names Click here for help
INN number INN
12711 labuxtinib
Synonyms Click here for help
Compound 1 [WO2022109595] | example F91 [WO2013033070] | THB-335 | THB335
Database Links Click here for help
BindingDB Ligand 193999
CAS Registry No. 1426449-01-5 (source: WHO INN record)
ChEMBL Ligand CHEMBL3962292
GtoPdb PubChem SID 485205991
PubChem CID 71280305
Search Google for chemical match using the InChIKey RHNJOZCVGSBEAG-KBPBESRZSA-N
Search Google for chemicals with the same backbone RHNJOZCVGSBEAG
Search PubMed clinical trials labuxtinib
Search PubMed titles labuxtinib
Search PubMed titles/abstracts labuxtinib
UniChem Compound Search for chemical match using the InChIKey RHNJOZCVGSBEAG-KBPBESRZSA-N
UniChem Connectivity Search for chemical match using the InChIKey RHNJOZCVGSBEAG-KBPBESRZSA-N

Product suppliers

View disclaimer

MedChemExpress
Labuxtinib (links to external site)
Cat. No. HY-156619